Winton Capital »

BioCryst Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $507k 53k 9.52
2025-12-31 $122k 16k 7.80
2019-03-31 $125k 15k 8.14